Baird raised the firm’s price target on Teradyne (TER) to $305 from $195 and keeps an Outperform rating on the shares. The firm updated its model following better than expected Q4 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne price target raised to $325 from $215 at Citi
- Teradyne price target raised to $300 from $230 at Goldman Sachs
- Teradyne: AI-Driven Test Demand and Expanding ATE Market Support Multi-Year Growth and Buy Rating
- Teradyne price target raised to $288 from $229 at Morgan Stanley
- Early notable gainers among liquid option names on February 3rd